Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cardinal Health (CAH)
NYSE:CAH
Holding CAH?
Track your performance easily
CAH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$93.17 - $126.23
Previous Close$118.28
Volume9.31M
Average Volume (3M)2.21M
Market Cap
$28.63B
Enterprise Value$30.92B
Total Cash (Recent Filing)$2.87B
Total Debt (Recent Filing)$5.16B
Price to Earnings (P/E)23.0
Beta0.51
Next Earnings
Jan 30, 2025EPS Estimate
$1.76Next Dividend Ex-Date
Jan 02, 2025Dividend Yield1.7%
Share Statistics
EPS (TTM)5.15
Shares Outstanding242,010,503
10 Day Avg. Volume6,736,090
30 Day Avg. Volume2,207,406
Standard Deviation0.08
R-Squared0.18
Alpha0.01
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)-8.74
Price to Sales (P/S)0.13
Price to Cash Flow (P/CF)-4.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.14
Enterprise Value/Gross Profit4.17
Enterprise Value/Ebitda10.88
Forecast
1Y Price Target
$132.46Price Target Upside11.99% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Cardinal Health News
PremiumCompany Announcements
Cardinal Health Expands with $2.9 Billion FundraisingBulls Say, Bears Say
Bulls Say
Acquisition StrategyCardinal Health's acquisition of GI Alliance and Advanced Diabetes Supply Group is seen as strategically smart and expected to add significant revenue and adjusted EBITDA, aligning with their strategy to invest in high-growth areas.
Financial PerformanceCardinal Health reported a solid financial quarter with adjusted earnings per share significantly above consensus estimates, showcasing strong operating momentum.
Future OutlookCardinal Health raised its fiscal year 2025 outlook, indicating confidence in future performance and highlighting the company's commitment to growth.
Bears Say
CompetitionION currently works with both COR and MCK, which means CAH will face competition in this space.
DebtCAH's recent acquisitions will add $5B of net debt to its balance sheet, though they remain committed to deleveraging to maintain their credit rating.
Segment PerformanceThe Global Medical Products and Distribution segment faced losses due to higher manufacturing and welfare costs.
---
Ownership Overview
0.26% Insiders
21.32% Mutual Funds
12.41% Other Institutional Investors
37.84% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CAH FAQ
What was Cardinal Health’s price range in the past 12 months?
Cardinal Health lowest stock price was $93.17 and its highest was $126.23 in the past 12 months.
What is Cardinal Health’s market cap?
Currently, no data Available
When is Cardinal Health’s upcoming earnings report date?
Cardinal Health’s upcoming earnings report date is Jan 30, 2025 which is in 38 days.
How were Cardinal Health’s earnings last quarter?
Cardinal Health released its earnings results on Nov 01, 2024. The company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.619 by $0.261.
Is Cardinal Health overvalued?
According to Wall Street analysts Cardinal Health’s price is currently Undervalued.
Does Cardinal Health pay dividends?
Cardinal Health pays a Thriceyearly dividend of $0.505 which represents an annual dividend yield of 1.7%. See more information on Cardinal Health dividends here
What is Cardinal Health’s EPS estimate?
Cardinal Health’s EPS estimate is $1.76.
How many shares outstanding does Cardinal Health have?
Cardinal Health has 242,010,500 shares outstanding.
What happened to Cardinal Health’s price movement after its last earnings report?
Cardinal Health reported an EPS of $1.88 in its last earnings report, beating expectations of $1.619. Following the earnings report the stock price went up 7.013%.
Which hedge fund is a major shareholder of Cardinal Health?
Among the largest hedge funds holding Cardinal Health’s share is Elliott Investment Management LP. It holds Cardinal Health’s shares valued at 221M.
---
Cardinal Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$132.46 (11.99% Upside)
$132.46 (11.99% Upside)
Blogger Sentiment
Bullish
CAH Sentiment 88%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 1.0M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $432.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.9%
Last 30 Days ▼ 7.9%
Last 30 Days ▼ 7.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
21.64%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-1.49%
Trailing 12-Months
Company Description
Cardinal Health
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The company operates through the following segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes cardinal health branded medical, surgical and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.
---
CAH Company Deck
---
CAH Earnings Call
Q1 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
Cardinal Health delivered a strong start to fiscal 2025, marked by significant growth in the Pharma segment and improved guidance for the year. However, challenges in the GMPD segment and potential cost impacts from tariffs pose risks that could affect future performance.Read More>---
CAH Revenue Breakdown
92.59% Pharmaceutical and Specialty Solutions
5.46% Global Medical Products and Distribution
1.99% Other
---
CAH Stock 12 Month Forecast
Average Price Target
$132.46
▲(11.99% Upside)
Technical Analysis
Best Analysts Covering CAH
1 Year
1 Year Success Rate
14/14 ratings generated profit
1 Year Average Return
+20.01%
reiterated a buy rating 2 months ago
Copying Kevin Caliendo's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +20.01% per trade.
---